AAM
EW icon

Abeille Asset Management’s Edwards Lifesciences EW Stock Holding History

Abeille Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$17.4M Sell
133,678
-462
-0.3% -$35.6K 0.62% 63
2022
Q3 		$11.1M Sell
134,140
-60,157
-31% -$5.79M 0.43% 64
2022
Q2 		$18.5M Sell
194,297
-327,479
-63% -$33.9M 0.65% 57
2022
Q1 		$61.4M Buy
521,776
+496,685
+1,980% +$55.7M 1.75% 14
2021
Q4 		$3.25M Buy
+25,091
New +$2.93M 0.75% 14

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Abeille Asset Management's EW Position: Q4 2022 in Review

Abeille Asset Management reduced its Edwards Lifesciences (EW) stake by 0.34% in Q4 2022, selling an estimated $35.6K and leaving 133,678 shares worth $17.4M. The position accounts for 0.62% of the portfolio, ranked #63.

Abeille Asset Management first reported a position in EW in Q4 2021 and has held it in 5 quarters since. The position peaked at $61.4M in Q1 2022. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2022.

  • Abeille Asset Management held 133,678 shares of Edwards Lifesciences worth $17.4M as of Q4 2022.
  • Abeille Asset Management sold 462 Edwards Lifesciences shares in Q4 2022, an estimated $35.6K.
  • Edwards Lifesciences made up 0.62% of Abeille Asset Management's portfolio in Q4 2022, its #63 holding.
  • Abeille Asset Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 5 quarters since.
  • Abeille Asset Management's Edwards Lifesciences position peaked at $61.4M in Q1 2022.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Abeille Asset Management's 13F filing for Q4 2022, filed 20 Jan 2023.